Core Viewpoint - The recent stock placement by 科笛-B (02487) has successfully raised approximately HKD 243 million, indicating strong investor interest and confidence in the company's future prospects [1] Group 1: Stock Placement Details - On September 5, shareholders of 科笛-B deposited shares worth HKD 286 million into Huatai Hong Kong, representing 8.26% of the total market value [1] - The placement involved the successful distribution of a total of 28.904 million shares to TruMed Health Innovation Fund LP, Octagon Investments Master Fund LP, and Octagon Private Opportunities Fund II LP at a price of HKD 8.40 per share [1] - The total proceeds from the placement amounted to approximately HKD 243 million, with net proceeds around HKD 240 million after expenses [1]
科笛-B(02487)股东将股票存入华泰香港 存仓市值2.86亿港元